{
    "id": 23603,
    "cites": 67,
    "cited_by": 0,
    "reference": [
        "Aakvik, A. et al. 2005. Estimating Treatment Effects for Discrete Outcomes when Responses to Treatment Vary: An Application to Norwegian Vocational Rehabilitation Programs. Journal of Econometrics 125: 15-51.",
        "Abadie, A. 2002. Bootstrap Tests for Distributional Treatment Effects in Instrumental Variable Models. JASA 97: 284-292.",
        "Abbring, J.H. and J.J. Heckman. 2007. Econometric Evaluation of Social Programs, Part III: Distributional Treatment Effects, Dynamic Treatment Effects, Dynamic Discrete Choice, and General Equilibrium Policy Evaluation. Chapter 72 in J.J. Heckman and E.E. Leamer, Eds., Handbook of Econometrics, Vol. 6B. Amsterdam: Elsevier.",
        "Abrevaya, J. 2000. Testing for a Treatment Effect in a Heterogeneous Population: A Modified Sign-Test Statistic and a Leapfrog Statistic. Journal of Applied Statistics 27: 679-687.",
        "Adams, C.P. 2013. Median Survival, Hazard Ratios, and Bounding Drug Effectiveness. Working Paper, U.S. Federal Trade Commission.",
        "Allison, R.A. and J.E. Foster. 2004. Measuring Health Inequality Using Qualitative Data. Journal of Health Economics 23: 505-524.",
        "Andrews, D.W.K. 1997. A Conditional Kolmogorov Test. Econometrica 65: 1097-1128.",
        "Angrist, J.D. 2004. Treatment Effect Heterogeneity in Theory and Practice. Economic Journal 114: C52-C83.",
        "Athey, S. and G.W. Imbens. 2006. Identification and Inference in Nonlinear Difference-inDifferences Models. Econometrica 74: 431-497.",
        "Atkinson, A.B. 2003. Multidimensional Deprivation: Contrasting Social Welfare and Counting Approaches. Journal of Economic Inequality 1: 51-65.",
        "Basu, A. et al. 2007. Use of Instrumental Variables in the Presence of Heterogeneity and SelfSelection: An Application to Treatments of Breast Cancer Patients. Health Economics 16: 1133-1157.",
        "Basu, A. and R. Thariani. 2016. Jointness Box (JB)-Area: A Novel Metric to Contemplate Potential Value of Individualized Care from Traditional Trials Data. Working Paper, Univ. of Washington.",
        "Bitler, M.P. et al. 2006. What Mean Impacts Miss: Distributional Effects of Welfare Reform Experiments. American Economic Review 96: 988-1012.",
        "Borah, B.J. et al. 2011. Assessing the Impact of High Deductible Health Plans on Health-Care Utilization and Cost: A Changes-in-Changes Approach. Health Economics 20: 1025-1042.",
        "Borghaei, H. et al. 2015. Nivolumab versus Docetaxel in Advanced Nonsquamous Non-SmallCell Lung Cancer. NEJM 373: 1627-1639.",
        "Cameron, A.C. et al. 2004. Modelling the Differences in Counted Outcomes using Bivariate Copula Models with Application to Mismeasured Counts. Econometrics Journal 7: 566584.",
        "Carneiro, P. et al. 2001. Removing the Veil of Ignorance in Assessing the Distributional Impacts of Social Policies. Swedish Economic Policy Review 8: 273-301.",
        "Castagnoli, E. 1984. Some Remarks on Stochastic Dominance. Revista di Matematica per le Scienze Economiche e Sociali 7: 15-28.",
        "Chan, T.Y. and B.H. Hamilton. 2006. Learning, Private Information, and the Economic Evaluation of Randomized Experiments. Journal of Political Economy 114: 997-1040.",
        "Coate, S. 2000. An Efficiency Approach to the Evaluation of Policy Changes. Economic Journal 110: 437-455.",
        "Darling, D.A. 1957. The Kolmogorov-Smirnov, Cram\u00c3\u0083\u00c2\u00a9r-von Mises Tests. Annals of Mathematical Statistics 28: 823-838.",
        "Denuit, M. et al. 2002. Measuring the Impact of Dependence between Claims Occurrences. Insurance: Mathematics and Economics 30: 1-19.",
        "Fan, Y. et al. 2014. Identifying Treatment Effects under Data Combination. Econometrica 82: 811-822.",
        "Fan, Y. et al. 2017. Partial Identification of Functionals of the Joint Distribution of 'Potential Outcomes'. Journal of Econometrics 197: 42-59.",
        "Fan, Y. and S.S. Park. 2010. Sharp Bounds on the Distribution of Treatment Effects and Their Statistical Inference. Econometric Theory 26: 931-951.",
        "Fan, Y. and S.S. Park. 2012. Confidence Intervals for the Quantile of Treatment Effects in Randomized Experiments. Journal of Econometrics 167: 330-344.",
        "Fenwick, E. et al. 2004. Cost-Effectiveness Acceptability Curves\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009dFacts, Fallacies and Frequently Asked Questions. Health Economics 13: 405-415.",
        "Firpo, S. and G. Ridder. 2008. Bounds on Functionals of the Distribution of Treatment Effects. Univ. of Southern California, IEPR Working Paper 08.09.",
        "Gastwirth, J.L. 1975. Statistical Measures of Earnings Differentials. The American Statistician 29: 32-35.",
        "Gerber, E.R. and J.B. Lewis. 2004. Beyond the Median: Voter Preferences, District Heterogeneity, and Political Representation. Journal of Political Economy 112: 1364-1383.",
        "Hansen, B.E. 2017. Econometrics (online textbook). University of Wisconsin-Madison, Dept. of Economics.",
        "Hauck, W.W. et al. 2000. Generalized Treatment Effects for Clinical Trials. Statistics in Medicine 19: 887-899.",
        "Heckman, J.J. et al. 1997. Making the Most out of Programme Evaluations and Social Experiments: Accounting for Heterogeneity in Programme Impacts. Review of Economic Studies 64: 487-535.",
        "Heckman, J.J. 2001. Accounting for Heterogeneity, Diversity and General Equilibrium in Evaluating Social Programmes. Economic Journal 111: F654-F699.",
        "Horwitz, R.I. et al. 1996. Can Treatment That Is Helpful on Average Be Harmful to Some Patients? A Study of the Conflicting Information Needs of Clinical Inquiry and Drug Regulation. Journal of Clinical Epidemiology 49: 395-400.",
        "Huang, E.J. et al. 2016. Inequality in Treatment Benefits: Can We Determine If a New Treatment Benefits the Many or the Few? Biostatistics (E-pub. ahead of print).",
        "Imbens, G.W. and C.F. Manski. 2004. Confidence Intervals for Partially Identified Parameters. Econometrica 72: 1845-1857.",
        "Imbens, G.W. and J.M. Wooldridge. 2009. Recent Developments in the Econometrics of Program Evaluation. Journal of Economic Literature 47: 5-86.",
        "Jacob, J. and D. Lundin. 2005. A Median Voter Model of Health Insurance with Ex Post Moral Hazard. Journal of Health Economics 24: 407-426.",
        "Koenker, R. and Y. Bilias. 2001. Quantile Regression for Duration Data: A Reappraisal of the Pennsylvania Reemployment Bonus Experiments. Empirical Economics 26: 199-220.",
        "Kotz, S. and J.P. Seeger. 1993. Lower Bounds on Multivariate Distributions with Preassigned Marginals. Stochastic Inequalities 22 (IMS Lecture Notes\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009dMonograph Series): 211-218.",
        "Kravitz, R.L. et al. 2004. Evidence-Based Medicine, Heterogeneity of Treatment Effects, and the Trouble with Averages. Milbank Quarterly 82: 661-687.",
        "Langley, R.G. et al. 2014. Secukinumab in Plaque Psoriasis\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009dResults of Two Phase 3 Trials. NEJM 371: 326-338.",
        "Lee, J.D. et al. 2016. Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders. NEJM 374: 1232-1242.",
        "Lee, M.-J. 2000. Median Treatment Effects in Randomized Trials. JRSS-B 62: 595-604.",
        "Lee, M.-J. and S. Kobayashi. 2001. Proportional Treatment Effects for Count Response Panel Data: Effects of Binary Exercise on Health Care Demand. Health Economics 10: 411-428.",
        "Lynn, J. et al. 2015. Value-Based Payments Require Valuing What Matters to Patients. JAMA 314: 1445-1446.",
        "Makarov, G.D. 1982. Estimates for the Distribution Function of a Sum of Two Random Variables When the Marginal Distributions are Fixed. Theory of Probability & Its Applications 26: 803-806.",
        "Manski, C.F. 1988. Analog Estimation Methods in Econometrics. London: Chapman and Hall.",
        "Manski, C.F. 1996. Learning about Treatment Effects from Experiments with Random Assignment of Treatments. Journal of Human Resources 31: 709-733.",
        "Manski, C.F. 1997. Monotone Treatment Effect. Econometrica 65: 1311-1334.",
        "Manski, C.F. 2007. Identification for Prediction and Decision. Harvard University Press.",
        "Mullahy, J. 2005. Individual Results May Vary. Working Paper, Presented at the Conference on the Economics of Addiction and Health Inequality, Barcelona (May 2005).",
        "Nissen, S.E. et al. 2016. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. NEJM 375: 2519-2529.",
        "Nolan, T. and D.M. Berwick. 2006. All-or-None Measurement Raises the Bar on Performance. JAMA 295: 1168-1170.",
        "Reck, M. et al. 2016. Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. NEJM 375: 1823-1833.",
        "R\u00c3\u0083\u00c2\u00bcschendorf, L. 2004. Comparison of Multivariate Risks and Positive Dependence. Journal of Applied Probability 41: 391-406.",
        "Stinnett, A.A. and J. Mullahy. 1998. Net Health Benefits: A New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis. Medical Decision Making 18: S68-S80.",
        "Tamer, E. 2010. Partial Identification in Econometrics. Annual Review of Economics 2: 167195.",
        "U.S. Food and Drug Administration. 2015. Clinical Trial Endpoints for the Approval of NonSmall Cell Lung Cancer Drugs and Biologics\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009dGuidance for Industry. USDHHS/FDA CBER/CDER.",
        "U.S. Food and Drug Administration. 2016. Non-Inferiority Trials to Establish Effectiveness\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d Guidance for Industry. USDHHS/FDA CBER/CDER.",
        "U.S. Food and Drug Administration. 2017. Multiple Endpoints in Clinical Trials\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009dGuidance for Industry. USDHHS/FDA CBER/CDER.",
        "van Hout, B.A. et al. 1994. Costs, Effects and C/E-Ratios alongside a Clinical Trial. Health Economics 3: 309-319.",
        "Volpp, K.G. et al. 2009. A Randomized, Controlled Trial of Financial Incentives for Smoking Cessation. NEJM 360: 699-709.",
        "Willan, A.R. 2001. On the Probability of Cost-Effectiveness Using Data from Randomized Clinical Trials. BMC Medical Research Methodology 1:8.",
        "Willke, R.J. et al. 2012. From Concepts, Theory, and Evidence of Heterogeneity of Treatment Effects to Methodological Approaches: A Primer. BMC Medical Research Methodology 12: 185.",
        "Williamson, R.C. and T. Downs. 1990. Probabilistic Arithmetic. I. Numerical Methods for Calculating Convolutions and Dependency Bounds. International Journal of Approximate Reasoning 4: 89-158."
    ]
}